Malaysia to study cancer diagnostic test
dc.contributor.author | Anon | |
dc.date.accessioned | 2019-10-08T02:43:31Z | |
dc.date.available | 2019-10-08T02:43:31Z | |
dc.date.issued | 2018-12-18 | |
dc.identifier.citation | 8 p., 3 col. | en_US |
dc.identifier.uri | http://dspace.unimap.edu.my:80/xmlui/handle/123456789/62188 | |
dc.language.iso | en | en_US |
dc.publisher | New Straits Times | en_US |
dc.subject | Health | en_US |
dc.subject | Clinical studies | en_US |
dc.subject | Ovarian cancer diagnostics blood test | en_US |
dc.subject | Clinical Research Malaysia (CRM) | en_US |
dc.subject | InterVenn BioSciences | en_US |
dc.title | Malaysia to study cancer diagnostic test | en_US |
dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
-
Newspaper Articles [41203]
Newspaper Articles